Rohto Pharmaceutical Co Ltd
Rohto Pharmaceutical's Climate Target Data Preview
As of 2024, Rohto Pharmaceutical has disclosed 2 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 2 absolute reduction targets, signaling the company’s commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Rohto Pharmaceutical ’s climate strategy, ambition level, and alignment with global decarbonization goals.
| Target Type | Scope of Target | Unit | Target | Target Year |
|---|---|---|---|---|
Absolute-based Target* | Scope 1 - Total, Scope 2 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | Copy restricted. Please purchase to unlock this data.  | 2025 |
Absolute-based Target* | Scope 1 - Total, Scope 2 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | Copy restricted. Please purchase to unlock this data.  | 2030 |
This table provides a simplified preview of selected climate targets data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Rohto Pharmaceutical's Greenhouse Gas Emissions Pathways
As of 2024, Rohto Pharmaceutical has set greenhouse gas (GHG) emissions reduction targets that cover its operational emissions (Scope 1 and 2), but not its value chain emissions (Scope 3). This means its reduction efforts currently focus on direct and purchased energy emissions.
Does Rohto Pharmaceutical have a target to reduce the emissions from its operations?
As of 2024, Rohto Pharmaceutical has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources.
Rohto Pharmaceutical's most ambitious operational target is to reduce these emissions by 46% by 2030, compared to a baseline of 15,823.383 Metric Tonnes of CO2 equivalent (mtCO2e) in 2013.
As of 2023, Rohto Pharmaceutical is lagging behind on its operational emissions reduction target, having achieved 42.61% of the planned reduction.